Development and application of oxidative stress biomarkers

References

• Babior BM. Phagocytes and oxidative stress. Am J Med. 2000;109:33–44.10.1016/S0002-9343(00)00481-2
   PubMed Web of Science ®Google Scholar
• Zhang R, Brennan ML, Shen Z, et al. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at a site of inflammation. J Biol Chem. 2002;277:46116–46122.10.1074/jbc.M209124200
   PubMed Web of Science ®Google Scholar
• Senthilmohan R, Kettle AJ. Bromination and chlorination reaction of myeloperoxidase at physical concentrations of bromide and chloride. Arch Biochem Biophys. 2006;445:235–244.10.1016/j.abb.2005.07.005
   PubMed Web of Science ®Google Scholar
• Brennan ML, Anderson MM, Shih DM, et al. Increased atherosclerosis in myeloperoxidase-deficient mice. J Clin Invest. 2001;107:419–430.10.1172/JCI8797
   PubMed Web of Science ®Google Scholar
• Kato Y, Kitamoto N, Kawai Y, et al. The hydrogen peroxide/copper ion system, but not other metal-catalyzed oxidation systems, produces protein-bound dityrosine. Free Radical Biol Med. 2001;31:624–632.10.1016/S0891-5849(01)00623-2
   PubMed Web of Science ®Google Scholar
• Kato Y, Maruyama W, Naoi M, et al. Immunohistochemical detection of dityrosine in lipofuscin pigments in the aged human brain. FEBS Lett. 1998;439:231–234.10.1016/S0014-5793(98)01372-6
   PubMed Web of Science ®Google Scholar
• Kato Y, Wu X, Naito M, et al. Immunochemical detection of protein dityrosine in atherosclerotic lesion of apo-E-deficient mice using a novel monoclonal antibody. Biochem Biophys Res Commun. 2000;275:11–15.10.1006/bbrc.2000.3265
   PubMed Web of Science ®Google Scholar
• Kato Y, Kawai Y, Morinaga H, et al. Immunogenicity of a brominated protein and successive establishment of a monoclonal antibody to dihalogenated tyrosine. Free Radical Biol Med. 2005;38:24–31.10.1016/j.freeradbiomed.2004.09.013
   PubMed Web of Science ®Google Scholar
• Ishitsuka Y, Masunaga T, Koide C, et al. Repeated irradiation with suberythermal ultraviolet B reduces the number of epidermal Langerhans cells. Arch Dermatol Res. 2003;295:155.10.1007/s00403-003-0397-4
   PubMed Web of Science ®Google Scholar
• Ishitsuka Y, Maniwa F, Koide C, et al. Detection of modified tyrosines as an inflammation marker in a photo-aged skin model. Photochem Photobiol. 2007;83(3):698–705.10.1562/2006-07-24-RA-978
   PubMed Web of Science ®Google Scholar
• Ishitsuka Y, Maniwa F, Koide C, et al. Clinical and experimental dermatology, increased halogenated tyrosine levels are useful markers of human skin ageing reflecting denatured proteins by the past skin inflammation. Clin Exp Dermatol. 2012;37:252–258.
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biol Med. 1991;11:81–128.10.1016/0891-5849(91)90192-6
   PubMed Web of Science ®Google Scholar
• Kato Y, Mori Y, Makino Y, et al. Formation of N(epsilon)-(hexanonyl)lysine in protein exposed to lipid hydroperoxide. A plausible marker for lipid hydroperoxide-derived protein modification. J Biol Chem. 1999;274:20406–20414.10.1074/jbc.274.29.20406
   PubMed Web of Science ®Google Scholar
• Fukuchi Y, Miura Y, Nabeno Y, et al. Immunohistochemical detection of oxidative stress biomarkers, dityrosine and N(epsilon)-(hexanoyl)lysine, and C-reactive protein in rabbit atherosclerotic lesions. J Atheroscler Thromb. 2008;15:185–192.10.5551/jat.E543
   PubMed Web of Science ®Google Scholar
• Kawai Y, Kato Y, Fujii H, et al. Immunochemical detection of a novel lysine adduct using an antibody to linoleic acid hydroperoxide-modified protein. J Lipid Res. 2003;44:1124–1131.10.1194/jlr.M200442-JLR200
   PubMed Web of Science ®Google Scholar
• Kawai Y, Fujii H, Kato Y, et al. Esterified lipid hydroperoxide-derived modification of protein: formation of a carboxyalkylamide-type lysine adduct in human atherosclerotic lesions. Biochem Biophys Res Commun. 2004;313:271–276.10.1016/j.bbrc.2003.11.123
   PubMed Web of Science ®Google Scholar
• Kawai Y, Fujii H, Okada M, et al. Formation of N(epsilon)-(succinyl)lysine in vivo: a novel marker for docosahexaenoic acid-derived protein modification. J Lipid Res. 2006;47:1386–1398.10.1194/jlr.M600091-JLR200
   PubMed Web of Science ®Google Scholar
• Kato Y, Miyake Y, Yamamoto K, et al. Preparation of a monoclonal antibody to N(epsilon)-(hexanonyl)lysine: application to the evaluation of protective effects of flavonoid supplementation against exercise-induced oxidative stress in rat skeletal muscle. Biochem Biophys Res Commun. 2000;274:389–393.10.1006/bbrc.2000.3150
   PubMed Web of Science ®Google Scholar
• Hisaka S, Kato Y, Kitamoto N, et al. Chemical and immunochemical identification of propanoylllysine derived from oxidized n-3 polyunsaturated fatty acid. Free Radical Biol Med. 2009;46:1463–1471.10.1016/j.freeradbiomed.2009.02.030
   PubMed Web of Science ®Google Scholar
• Kato Y, Yoshida A, Naito M, et al. Identification and quantification of N(epsilon)-(hexanoyl)lysine in human urine by liquid chromatography/tandem mass spectrometry. Free Radical Biol Med. 2004;37:1864–1874.10.1016/j.freeradbiomed.2004.09.007
   PubMed Web of Science ®Google Scholar
• Galvan A, Wichmann T. Pathophysiology of Parkinsonism. Clin Neurophysiol. 2008;119:1459–1474.10.1016/j.clinph.2008.03.017
   PubMed Web of Science ®Google Scholar
• Schapira AH. Cause of neuronal death in Parkinson’s disease. Adv Neurol. 2001;86:155–162.
   PubMedGoogle Scholar
• Jenner P. Oxidative stress in Parkinson’s disease. Ann Neurol. 2003;53:S26–S38.10.1002/(ISSN)1531-8249
   PubMed Web of Science ®Google Scholar
• Porter NA, Caldwell SE, Mills KA. Mechanisms of free radical oxidation of unsaturated lipids. Lipids. 1995;30:277–290.10.1007/BF02536034
   PubMed Web of Science ®Google Scholar
• Hadders-Algra M. Prenatal long-chain polyunsaturated fatty acid status: the importance of a balanced intake of docosahexanoic acid and arachidonic acid. J Perinat Med. 2008;36:101–109.
   PubMed Web of Science ®Google Scholar
• Liu XB, Shibata T, Hisaka S, et al. DHA hydroperoxides as a potential inducer of neuronal cell death: a mitochondrial dysfunction-mediated pathway. J Clin Biochem Nutr. 2008;43(1):26–33.10.3164/jcbn.2008040
   PubMed Web of Science ®Google Scholar
• Liu XB, Yamada N, Maruyama W, et al. Formation of dopamine adducts derived from brain polyunsaturated fatty acids: mechanism for Parkinson’s disease. J Biol Chem. 2008;283(50):34887–34895.10.1074/jbc.M805682200
   PubMed Web of Science ®Google Scholar
• Tsuji K, Kawai Y, Kato Y, et al. Formation of Ne -(hexanoyl)ethanolamine, a novel phosphatidylethanolamine adduct, during the oxidation of erythrocyte membrane and low-density lipoprotein. Biochem Biophys Res Commun. 2003;306:706–711.10.1016/S0006-291X(03)01038-6
   Google Scholar
• Linderkamp O, Friederichs E, Boehler T, et al. Age dependency of red blood cell deformability and density: studies in transient erythroblastopenia of chilidhood. Br J Haematol. 1993;83:125–129.10.1111/j.1365-2141.1993.tb04642.x
   PubMed Web of Science ®Google Scholar
• Hisaka S, Yamada N, Naito K, et al. The immunological and chemical detection of N-(hexanoyl) phosphatidylethanolamine and N-(hexanoyl)- phosphatidylserine in an oxidative model induced by carbon tetrachloride. Biochem Biophys Res Commun. 2010;393:631–636.10.1016/j.bbrc.2010.02.043
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Tanaka T, Hattori Y, et al. Quantitative Immuunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest. 1997;76(3):365–374.
   PubMed Web of Science ®Google Scholar
• Erhola M, Toyokuni S, Okada K, et al. Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8-hydroxy-2′-deoxyguanosine excretion with radiotherapy, chemotherapy and response to treatment. FEBS Lett. 1997;409:287–291.10.1016/S0014-5793(97)00523-1
   PubMed Web of Science ®Google Scholar
• Ahmed NU, Ueda M, Nikaido O, et al. High level of 8-hydroxy-2′-deoxyguanosine appear in normal human epidermis after single dose of ultraviolet radiation. British J Dermantol. 1999;140:226–231.10.1111/j.1365-2133.1999.02653.x
   PubMed Web of Science ®Google Scholar
• Chung F-L, Chen H-JC, Nath RG. Lipid peroxidation as a potential endogenous source for the formation of exocyclic DNA adducts. Carcinogenesis. 1996;17(10):2105–2111.10.1093/carcin/17.10.2105
   PubMed Web of Science ®Google Scholar
• Kawai Y, Kato Y, Nakae D, et al. Immunohistochemical detection of a substituted 1, N2-ethenodeoxyguanosine adduct by ω-6 polyunsaturated fatty acid hydroperoxides in the liver of rats fed a choline-deficient, L-amino acid-defined diet. Carcinogenesis. 2002;23:485–489.
   PubMed Web of Science ®Google Scholar
• Kawai Y, Uchida K, Osawa T. 2′-Deoxycytidine in free nucleosides and double-stranded DNA as the major target by lipid peroxidation products. Free Radical Biol Med. 2004;36:529–541.10.1016/j.freeradbiomed.2003.12.006
   PubMed Web of Science ®Google Scholar
• Henderson JP, Byun J, Williams MV, et al. Bromination of deoxycytidine by eosinophil peroxidase: a mechanism for mutagenesis by oxidative damage of nucleotide precursors. Proc Nat Acad Sci USA. 2001;98:1631–1636.10.1073/pnas.98.4.1631
   PubMed Web of Science ®Google Scholar
• Masuda M, Suzuki T, Friesen M, et al. Chlorination of guanosine and other nucleosides by hypochlorous acid and myeloperoxidase of activated human neutrophils. J Biol Chem. 2001;276:40486–40496.
   PubMed Web of Science ®Google Scholar
• Asahi T, Kondo H, Masuda M, et al. Chemical and immunochemical detection of 8-halogenated deoxyguanosines at early stage inflammation. J Biol Chem. 2010;285:9282–9291.10.1074/jbc.M109.054213
   PubMed Web of Science ®Google Scholar
• Asahi T, Nakamura Y, Kato Y, et al. Specific role of taurine in the 8-brominated-2′-deoxyguanosine formation. Arch Biochem Biophys. 2015;586:45–50.10.1016/j.abb.2015.10.002
   PubMed Web of Science ®Google Scholar
• Hoshino F, Watanabe O, Wu X, et al. Low-cost and easy-to-use “on-chip ELISA” for developing health-promoting foods. In: Kato Y, editor. Lipid hydroperoxidederived modification of biomolecules. New York (NY): Springer; 2014. p. 151–161.10.1007/978-94-007-7920-4
   Google Scholar
• Ito T, Kato M, Tsuchida H, et al. Ergothioneine as an anti-oxidative/anti-inflammatory component in several edible mushrooms. Food Sci Technol Res. 2011;17(2):103–110.10.3136/fstr.17.103
   Web of Science ®Google Scholar
• Asahi T, Wu X, Shimoda H, et al. A mushroom-derived amino acid, ergothioneine, is a potential inhibitor of inflammation-related DNA halogenation. Biosci Biotechnol Biochem. 2016;80(2):313–317.10.1080/09168451.2015.1083396
   PubMed Web of Science ®Google Scholar
• Liu X, Yamada N, Osawa T. Assessing the neuroprotective effect of antioxidative food factors by application of lipid-derived dopamine modification adducts. Lipidomics Vol.2: Methods and Protocols. In: Armstrong D, editor. Methods in molecular biology. Vol. 580. London: Humana Press; 2009. p. 143–152.
   Google Scholar
• Miyake Y, Fukumoto S, Okada M, et al. Antioxidative catechol lignans converted from sesaminol triglucoside by culturing with Aspergillus. J Agric Food Chem. 2005;53(1):22–27.10.1021/jf048743 h
   PubMed Web of Science ®Google Scholar
• Kato Y, Miyake Y, Yamamoto K, et al. Preparation of monoclonal antibody to Nε-(Hexanonyl)lysine: application to the evaluation of oxidative modification of rat skeletal muscle by exercise with flavonoid supplimentation. Biochem Biophys Res Commun. 2000;274:389–393.10.1006/bbrc.2000.3150
   PubMed Web of Science ®Google Scholar
• Aoi W, Naito Y, Takanami Y, et al. Astaxanthin improves muscle lipid metabolism in exercise via inhibitory effect of oxidative CPT I modification. Biochem Biophys Res Commun. 2008;366:892–897.10.1016/j.bbrc.2007.12.019
   PubMed Web of Science ®Google Scholar
• Kazumura K, Sato Y, Satozono H, et al. Simultaneous monitoring of superoxides and intracellular calcium ions in neutrophils by chemiluminescence and fluorescence: Evaluation of action mechanisms of bioactive compounds in foods. J Pharm Biomed Anal. 2013;84:90–96.10.1016/j.jpba.2013.05.048
   PubMed Web of Science ®Google Scholar
• Kazumura K, Sato Y, Mochizuki M, et al. A study on health promoting power in astaxanthin by using dual-mode observation of innate immune responses in neutrophils, ACN2015; May 16; Yokohama; 2015.
   Google Scholar
• Wu YQ, Shamoto-Nagai M, Maruyama W, et al. Phytochemicals prevent mitochondrial membrane permeabilization in apoptosis induced by PK11195: A novel cellular mechanism underlying the neuroprotective anti-aging function of bioactive dietary compounds. J Neural Transm. 2017;124:89–98.10.1007/s00702-016-1624-4
   PubMedGoogle Scholar
• Kato Y, Osawa T. Detection of lipid-lysine amide-type adduct as a marker of PUFA oxidation and its applications. Arch Biochem Biophys. 2010;501:182–187.10.1016/j.abb.2010.06.010
   PubMed Web of Science ®Google Scholar